The Canadian Psychedelic Businesses Association

We are
PsyCan

A not-for-profit trade association representing Canadian psychedelic medicine and therapy companies.

About Us

News Item — Jul 17, 2023

Empower Psychedelics preparing for clinical trials through the Special Access Program

Read

News Item — Jul 14, 2023

Check out MAPS Canada's ongoing seminars on fascinating issues related to psychedelic medicine and therapy through their #SchoolofPsychedelics.

Read

Press Release — Jun 30, 2023

Canadian Psychedelic Medicine and Therapy Sector Welcomes Initial Federal Investment in Psychedelic Medical Research

Read

Psychedelics for mental health care

We champion the benefits of scientifically-proven, psychedelic-assisted therapies administered by qualified practitioners to Canadians suffering from chronic mental health conditions.

Newsroom

Advancing the psychedelics industry

We are dedicated to advocating on behalf of, and improving the regulatory landscape for, the legal psychedelics industry in Canada.

About us

Become a member

We represent researchers, medical practitioners, labs, clinics, drug developers, and suppliers producing and working with psychedelic medicine.

Membership

Leading the
charge for change

Our members are some of Canada’s industry leaders in pharmaceuticals, psychedelics, and mental health research. Together we seek to educate and better understand how psychedelics can improve mental health outcomes and well-being.

More about our members